Methods and compositions for treating melanoma
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Oct 12, 2010
Grant Date -
Aug 12, 2010
app pub date -
Jun 28, 2006
filing date -
Jun 29, 2005
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
mutant peptides or a pharmaceutically acceptable salt thereof, that induce MHC Class I-dependent cytotoxic T cell responses in mammals are useful in prophylactic, diagnostic and therapeutic treatments for melanoma. Such compounds are also useful in drug development for non-peptide mimics of the compounds described herein and in the development of therapeutic or diagnostic antibodies.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully